Fresenius SE KGaAXSWX:FRE 71 OCF Yield % is 12.94 as of Jun. 24, 2026, which is 21% below its 10-year median of 16.32. GuruFocus rates XSWX:FRE with a GF Score™ of 71/100 and a GF Value™ of CHF32.85 (Fairly Valued). The stock has 5 warning signs investors should review. Among 685 Healthcare Providers & Services companies, Fresenius SE KGaA ranks better than 76.93% on this metric.
OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.
The historical rank and industry rank for Fresenius SE KGaA's OCF Yield % or its related term are showing as below:
XSWX:FRE'
s OCF Yield % Range Over the Past 10 Years
Min: 7.88 Med: 16.32 Max: 36.53
Current: 12.94
During the past 13 years, the highest OCF Yield % of Fresenius SE KGaA was 36.53%. The lowest was 7.88%. And the median was 16.32%.
XSWX:FRE's OCF Yield % is ranked better than 76.93% of 685
companies
in the Healthcare Providers & Services industry
Industry Median: 5.56
vs XSWX:FRE: 12.94
Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Fresenius SE KGaA OCF Yield % Related Terms
Fresenius SE KGaA OCF Yield % Historical Data
* Premium members only.
The historical data trend for Fresenius SE KGaA's OCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Fresenius SE KGaA's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Fresenius SE KGaA OCF Yield % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Fresenius SE KGaA's OCF Yield % distribution charts can be found below:
* The bar in red indicates where Fresenius SE KGaA's OCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Fresenius SE KGaA (XSWX:FRE) has a OCF Yield % of 12.94 as of Jun. 24, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Fresenius SE KGaA and its competitors. This is 21% below median its historical median of 16.32. Over the past decade, Fresenius SE KGaA's OCF Yield % has ranged from 7.88 to 36.53. According to the industry distribution chart, Fresenius SE KGaA ranks #158 out of 685 companies in the Healthcare Providers & Services industry, placing it in the top 23.1%.
Is Fresenius SE KGaA's OCF Yield % too high?
Fresenius SE KGaA's current OCF Yield % of 12.94 is 21% below median its 10-year median of 16.32. Over the past 10 years, this metric has ranged from a low of 7.88 to a high of 36.53. The Healthcare Providers & Services industry median OCF Yield % is 5.56. Fresenius SE KGaA's value of 12.94 is 132.7% above this industry median. Based on the distribution chart, Fresenius SE KGaA ranks #158 out of 685 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Fresenius SE KGaA has a GF Score™ of 71/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Fresenius SE KGaA's OCF Yield % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Fresenius SE KGaA ranks #158 out of 685 companies for OCF Yield %. This places Fresenius SE KGaA in the top 23% of its industry — outperforming the majority of peers. The industry median OCF Yield % is 5.56. Fresenius SE KGaA's value of 12.94 is 132.7% above this benchmark. Historically, Fresenius SE KGaA's own OCF Yield % has ranged from 7.88 to 36.53 over the past decade. While the company's 10-year median is 16.32 vs. the industry median of 5.56, Fresenius SE KGaA has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Healthcare Providers & Services company?
The median OCF Yield % among Healthcare Providers & Services companies is 5.56, based on 685 companies in the industry. Companies in the top quartile (top 25%) have a OCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Fresenius SE KGaA's current OCF Yield % of 12.94 is 132.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Fresenius SE KGaA and its competitors. For the Healthcare Providers & Services industry, the median OCF Yield % is 5.56 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Fresenius SE KGaA's current OCF Yield % is 12.94, which is 21% below median its own 10-year median of 16.32. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fresenius SE KGaA stock overvalued right now?
Based on GuruFocus' analysis, Fresenius SE KGaA (XSWX:FRE) is currently considered Fairly Valued. The stock's GF Value™ is CHF32.85, compared to a current price of CHF35.86 — trading 9.2% above its estimated fair value. The current OCF Yield % is 12.94, which is 21% below median its 10-year median of 16.32 and 132.7% above the Healthcare Providers & Services industry median of 5.56. Fresenius SE KGaA's overall GF Score™ is 71/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For Fresenius SE KGaA (XSWX:FRE), the current OCF Yield % is 12.94 as of Jun. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Fresenius SE KGaA (XSWX:FRE) Overvalued in 2026?
Based on GuruFocus' analysis, Fresenius SE KGaA stock appears to be overvalued.
The current stock price of CHF35.86 is trading 9.2% above its estimated GF Value™ of CHF32.85.
GuruFocus considers Fresenius SE KGaA to be Fairly Valued.
Key valuation signals for XSWX:FRE:
OCF Yield %: 12.94 (21% below median its 10-year median of 16.32)
GF Value™: CHF32.85 vs. price of CHF35.86 (9.2% above fair value)
Industry Position: 132.7% above the Healthcare Providers & Services median (#158 of 685)
No single metric tells the full story. See the XSWX:FRE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Fresenius is a healthcare holding company based in Germany. The company owns a minority stake in dialysis service provider and equipment manufacturer Fresenius Medical Care. The Kabi segment manufactures intravenous drugs, nutrition products, infusion and transfusion therapies, and related pumps. The Helios segment operates private hospitals primarily in Germany and Spain.
71GF Score
Get the complete analysis for XSWX:FRE
OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:FRE has been successfully added to your 
